Sandoz Group AG (SDZNY)
OTCMKTS
· Delayed Price · Currency is USD
44.02
+0.14 (0.32%)
Aug 30, 2024, 4:00 PM EDT
Sandoz Group AG Company Description
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Sandoz Group AG
Country | Switzerland |
Founded | 1886 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 22,633 |
CEO | Richard Saynor |
Contact Details
Address: Forum 1 Basel, 4056 Switzerland | |
Phone | 41 61 324 11 11 |
Website | sandoz.com |
Stock Details
Ticker Symbol | SDZNY |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US7999261008 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Richard Saynor | Chief Executive Officer |
Remco J. Steenbergen | Chief Financial Officer |
Asaf Gal | Chief Technology Officer |
Claire D'Abreu-Hayling | Chief Scientific Officer |
Karen M. King | Head Global Investor Relations |
Ingrid Sollerer | General Counsel and Chief Compliance Officer |
Tripti Jha | Chief People Officer |
Francisco Ballester | President of International |
Pierre Bourdage | Chief Commercial Officer |
Dr. Glenn A. Gerecke Ph.D. | Chief Manufacturing and Supply Officer |